Sarissa is developing a range of minimally invasive, microelectrode electrochemical sensors for the measurement of the purines.. Founded in 2002, Sarissa Biomedical is backed by investors that include The Wood Family, Mercia’s EIS funds, Innovate UK, Mercia Fund Managers, and Midlands Engine Investment Fund and is headquartered in Coventry.